Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NAOV

NanoVibronix Inc

Dec 10 • 04:00PM ET

0.7000

Dollar change -0.0748
Percentage change -9.65	%

Healthcare • Medical Devices • USA • NASD

Peers: INVA IRIX STXS OFIX PAVM LUNA MLSS ATEC ASMB MVIS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.23	Insider Own	0.28%	Shs Outstand	3.75M	Perf Week	-5.41%
Market Cap	2.63M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.74M	Perf Month	7.86%
Income	-3.09M	PEG	-	EPS next Q	-	Inst Own	13.52%	Short Float	1.53%	Perf Quarter	8.56%
Sales	3.29M	P/S	0.80	EPS this Y	-	Inst Trans	366.84%	Short Ratio	0.31	Perf Half Y	-13.04%
Book/sh	0.67	P/B	1.04	EPS next Y	-	ROA	-51.27%	Short Interest	0.06M	Perf Year	-34.58%
Cash/sh	0.35	P/C	2.02	EPS next 5Y	-	ROE	-94.09%	52W Range	0.46 - 1.52	Perf YTD	-39.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.29%	ROI	-158.39%	52W High	-53.95%	Beta	1.62
Dividend TTM	-	Quick Ratio	0.84	Sales past 5Y	80.85%	Gross Margin	59.62%	52W Low	53.01%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	1.74	EPS Y/Y TTM	70.52%	Oper. Margin	-88.54%	RSI (14)	52.17	Volatility	10.50% 9.62%
Employees	16	Debt/Eq	0.07	Sales Y/Y TTM	-	Profit Margin	-93.80%	Recom	1.00	Target Price	10.50
Option/Short	No / Yes	LT Debt/Eq	0.04	EPS Q/Q	15.72%	Payout	-	Rel Volume	0.24	Prev Close	0.77
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-17.90%	Earnings	-	Avg Volume	184.22K	Price	0.70
SMA20	0.05%	SMA50	13.14%	SMA200	-2.31%	Trades		Volume	44,801	Change	-9.65%

Nov-12-24 08:00AM	NanoVibronix Provides Business Update (Business Wire) +5.97%
Oct-09-24 08:30AM	NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany (Business Wire)
Sep-23-24 08:30AM	NanoVibronix Signs Letter of Intent with Potential New Distributor (Business Wire)
Aug-21-24 08:30AM	NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders (Business Wire)
May-22-24 08:30AM	NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan (Business Wire)
08:30AM	Loading…
May-16-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
May-15-24 11:53PM	NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024 (InvestorPlace)
May-14-24 12:55PM	NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield (MT Newswires)
08:30AM	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield (Business Wire)
May-03-24 07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-01-24 08:00AM	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs FSS Contract Award (Business Wire) -6.12%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-24-24 01:00PM	NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 (ACCESSWIRE)
Apr-10-24 07:52AM	NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 (InvestorPlace) -9.15%
Apr-09-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
08:30AM	Loading…
Mar-28-24 08:30AM	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield (Business Wire)
Dec-06-23 09:00AM	NanoVibronix Featured in Your Bladder Health Magazine (Business Wire)
Dec-04-23 09:00AM	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity (Business Wire)
Nov-28-23 09:00AM	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan (Business Wire) -13.87%
Nov-21-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire) +9.16%
Nov-14-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Nov-07-23 08:30AM	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 (Business Wire)
Sep-27-23 08:00AM	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire)
Sep-06-23 08:30AM	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting (Business Wire) -8.48%
Aug-30-23 02:29PM	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (Business Wire) +67.59%
12:07PM	Why Is NanoVibronix Stock Trading Higher Today? (Benzinga)
08:30AM	NanoVibronix Cites Positive Results from Independent Testing of UroShield (Business Wire)
Aug-29-23 04:05PM	NanoVibronix Responds to CMS Determination for PainShield (Business Wire)
Aug-28-23 08:30AM	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire) -14.04%
Aug-23-23 08:45AM	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus (Business Wire) -5.62%
08:30AM	Loading…
Jun-14-23 08:30AM	NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard (Business Wire)
May-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Apr-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Mar-28-23 08:30AM	NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) (Business Wire)
Mar-21-23 08:30AM	NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra (Business Wire) +8.29%
Mar-14-23 09:15AM	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury (Business Wire)
Mar-03-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Feb-22-23 08:30AM	NanoVibronix to Launch Rental Program for PainShield and UroShield (Business Wire) +5.08%
Feb-08-23 12:00PM	NanoVibronix Announces Reverse Stock Split (Business Wire) -15.38%
Jan-18-23 08:30AM	NanoVibronix Provides Update on Expanding Access to PainShield (Business Wire) -7.57%
Dec-15-22 04:05PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire)
Dec-13-22 08:30AM	NanoVibronix Announces Partnership with Peak Medical, Ltd. (Business Wire)
Dec-09-22 06:11AM	Shareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptable (Simply Wall St.)
Dec-01-22 02:06PM	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Nov-29-22 08:07AM	NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -21.00%
Nov-28-22 03:18PM	NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus (Business Wire) +144.27%
Nov-17-22 06:23AM	NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021) (Simply Wall St.)
Nov-16-22 10:15AM	Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients (Benzinga)
08:30AM	NanoVibronix Announces Interim Results of Clinical Study for UroShield (Business Wire)
Nov-15-22 08:33AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Oct-19-22 08:30AM	NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement (Business Wire)
Sep-23-22 08:30AM	NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract (Business Wire) +25.17%
Sep-14-22 04:05PM	NanoVibronix Sets Date for Annual Shareholder Meeting (Business Wire)
09:25AM	NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock (Business Wire)
Sep-02-22 04:30PM	NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing (Business Wire) -14.88%
Aug-18-22 11:30AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Jul-25-22 08:30AM	Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely? (Simply Wall St.) -5.15%
Jul-12-22 08:30AM	NanoVibronix Announces Webinar Series to Promote UroShield (Business Wire)
Jun-29-22 08:30AM	NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability (Business Wire)
May-17-22 08:30AM	NanoVibronix Reports First Quarter 2022 Financial Results (Business Wire) +5.16%
May-04-22 08:30AM	NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS (Business Wire) +5.39%
Apr-25-22 08:30AM	NanoVibronix Adds Additional Product to Federal Supply Schedule (Business Wire) +7.40%
Apr-05-22 08:30AM	NanoVibronix Advances Efforts to Achieve NHS Approval (Business Wire) -7.63%
Mar-30-22 11:16AM	Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices (Benzinga) +22.64%
08:30AM	NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices (Business Wire)
Feb-14-22 01:45PM	Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -5.86%
Feb-07-22 08:30AM	NanoVibronix Added an Additional National Payer Network in Workers Compensation Market (Business Wire)
Jan-31-22 04:15PM	AM Best Upgrades Ratings of CNO Financial Group to A (Excellent) (PR Newswire)
Jan-24-22 08:30AM	NanoVibronix Extends Reach of UroShield and PainShield through MTSGs International Network (Business Wire)
Jan-19-22 08:30AM	NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology (Business Wire)
Jan-13-22 08:30AM	NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors (Business Wire)
Jan-07-22 01:02PM	NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Jan-06-22 08:30AM	NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC (Business Wire)
Jan-05-22 08:30AM	NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities (Business Wire) -7.27%
Dec-21-21 03:15PM	NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe (Benzinga)
10:30AM	NanoVibronix Adjourns Special Meeting of Stockholders (GlobeNewswire)
08:00AM	NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion (Business Wire)
Dec-15-21 09:01AM	11 Best One Dollar Stocks to Buy Today (Insider Monkey) +6.93%
Dec-08-21 11:10AM	CNO Financial Group Selects 2021 Holiday and New Year's Card Winner (PR Newswire)
08:30AM	NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15 (GlobeNewswire)
Dec-07-21 09:00AM	CNO Financial Group Names Richard Shaffer Senior Vice President (PR Newswire)
08:30AM	NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield (GlobeNewswire)
Dec-02-21 05:30AM	NanoVibronix Announces Early Success in the Marketing of Painshield to Veterans Administration Healthcare Providers (GlobeNewswire)
Nov-16-21 08:30AM	NanoVibronix Reports Third Quarter 2021 Financial Results (Business Wire) -9.72%
Oct-28-21 09:28AM	NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders (GlobeNewswire)
Oct-11-21 10:40AM	NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain (Benzinga) +17.65%
09:06AM	NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD (GlobeNewswire)
Sep-29-21 10:14AM	NANOVIBRONIX ENTERS WORKERS COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL (GlobeNewswire) +7.03%
Sep-14-21 12:12PM	NanoVibronix Launches CBD-Based Product For Pain Management (Benzinga) -9.46%
08:30AM	NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS (GlobeNewswire)
Aug-17-21 02:32PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire) -12.76%
10:26AM	We're Hopeful That NanoVibronix (NASDAQ:NAOV) Will Use Its Cash Wisely (Simply Wall St.)
07:02AM	25 Stocks Moving in Tuesday's Pre-Market Session (Benzinga)
Aug-16-21 04:05PM	NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update (GlobeNewswire) +33.73%
12:13PM	Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump (Benzinga)
10:22AM	Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August (Benzinga)
08:30AM	NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCH (GlobeNewswire)
Aug-11-21 08:30AM	NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIA (GlobeNewswire)
Aug-05-21 08:52AM	NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus® (Business Wire) +20.10%
Jul-29-21 09:00AM	NanoVibronix Receives Registration Approval for UroShield From TGA Australia (Business Wire) +26.18%

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAOV

NanoVibronix Inc

Upgrade your FINVIZ experience